| JYSB2300109 | 注射用巴利昔单抗 | basiliximab | Lyophilized | Biological Products | Supplementary Application | 2023-06-15 | | | | | view |
| JYSZ2200001 | 注射用巴利昔单抗 | basiliximab | Lyophilized | Biological Products | License Renew | 2022-01-05 | | | | | view |
| JYSB2100044 | 注射用巴利昔单抗 | basiliximab | Lyophilized | Biological Products | Supplementary Application | 2021-02-09 | 北京诺华制药有限公司 | Beijing Novartis Pharma Co Ltd | In Review | 2021-02-08 | view |
| JYSB2000248 | 注射用巴利昔单抗 | basiliximab | Lyophilized | Biological Products | Supplementary Application | 2020-06-19 | 北京诺华制药有限公司 | Beijing Novartis Pharma Co Ltd | Filed | 2020-06-22 | view |
| JYSB2000154 | 注射用巴利昔单抗 | basiliximab | Lyophilized | Biological Products | Supplementary Application | 2020-04-28 | 北京诺华制药有限公司 | Beijing Novartis Pharma Co Ltd | Filed | 2020-05-08 | view |
| JYSB1900211 | 注射用巴利昔单抗 | basiliximab | Lyophilized | Biological Products | Supplementary Application | 2019-08-26 | 北京诺华制药有限公司 | Beijing Novartis Pharma Co Ltd | Certificate Issued | 2020-09-27 | view |
| JYSB1800225 | 注射用巴利昔单抗 | basiliximab | Lyophilized | Biological Products | Supplementary Application | 2018-10-29 | 北京诺华制药有限公司 | Beijing Novartis Pharma Co Ltd | Certificate Issued | 2020-03-13 | view |
| JYSB1800011 | 注射用巴利昔单抗 | basiliximab | Lyophilized | Biological Products | Supplementary Application | 2018-02-02 | 北京诺华制药有限公司 | Beijing Novartis Pharma Co Ltd | Certificate Issued | 2018-07-30 | view |
| JYSZ1700027 | 注射用巴利昔单抗 | basiliximab | Lyophilized | Biological Products | License Renew | 2017-12-13 | 北京诺华制药有限公司 | Beijing Novartis Pharma Co Ltd | Approval Completed-Pending Certificated | 2018-01-08 | view |
| JYSB1600157 | 注射用巴利昔单抗 | basiliximab | Lyophilized | Biological Products | Supplementary Application | 2016-08-15 | 北京诺华制药有限公司 | Beijing Novartis Pharma Co Ltd | Certificate Issued | 2017-02-15 | view |
| JYSB1400175 | 注射用巴利昔单抗 | basiliximab | Lyophilized | Biological Products | Supplementary Application | 2014-08-13 | 北京诺华制药有限公司 | Beijing Novartis Pharma Co Ltd | Certificate Issued | 2016-01-12 | view |
| JYSB1000111 | 注射用巴利昔单抗 | basiliximab | Lyophilized | Biological Products | Supplementary Application | 2010-07-05 | 北京诺华制药有限公司 | Beijing Novartis Pharma Co Ltd | Certificate Issued | 2012-11-05 | view |
| JYSB1000112 | 注射用巴利昔单抗 | basiliximab | Lyophilized | Biological Products | Supplementary Application | 2010-07-05 | 北京诺华制药有限公司 | Beijing Novartis Pharma Co Ltd | Certificate Issued | 2012-11-05 | view |
| JYSZ0700011 | 注射用巴利昔单抗 | basiliximab | Lyophilized | Biological Products | License Renew | 2007-05-18 | | | Certificate Issued | 2008-03-17 | view |
| JYSZ0700012 | 注射用巴利昔单抗 | basiliximab | Lyophilized | Biological Products | License Renew | 2007-05-18 | | | Certificate Issued | 2008-03-17 | view |
| J0301094 | 注射用巴利昔单抗 | basiliximab | Lyophilized | Biological Products | Supplementary Application | 2004-03-24 | 香港诺华制药有限公司北京代表处 | | Certificate Issued | 2004-12-02 | view |
